Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 192

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 1
Chunk 192
---
 funds and could make our Class A common stock less attractive to other investors. As a result, the market price of our Class
A common stock may be adversely affected.

Our
principal stockholders will continue to have significant influence over the election of our board of directors and approval of any significant
corporate actions, including any sale of the Company.

Deepika
Vuppalanchi, our Chief Executive Officer and Priya Prasad, our Chief Financial Officer and Chief Operating Officer, in the aggregate,
beneficially own 51.0% of our Class B common stock and 30.9% of our outstanding voting securities. These stockholders currently have,
and likely will continue to have, significant influence with respect to the election of our board of directors and approval or disapproval
of all significant corporate actions. The concentrated voting power of these stockholders could have the effect of delaying or preventing
an acquisition of the Company or another significant corporate transaction.

We
could be subject to securities class action litigation.

In
the past, securities class action litigation has been brought against companies following a decline in the market price of their securities.
This risk is especially relevant for us because healthcare companies have experienced significant share price volatility in recent years.
If we face such litigation, it could result in substantial costs and a diversion of management’s attention and resources, which
could harm our business.

-23-

Anti-takeover
provisions contained in our Certificate of Incorporation and our Amended and Restated Bylaws (“Bylaws”), as well as provisions
of Delaware law, could impair a takeover attempt.

Our
Certificate of Incorporation, Bylaws and Delaware law contain provisions which could have the effect of rendering more difficult, delaying
or preventing an acquisition deemed undesirable by our board of directors. Our corporate governance documents include or will include
provisions:

    ●
    authorizing
    “blank check” preferred stock, which could be issued by our board of directors without stockholder approval and may contain
    voting, liquidation, dividend, and other rights superior to our Class A common stock;

    ●
    limiting
    the liability of, and providing indemnification to, our directors and officers;

    ●
    limiting
    the ability of our stockholders to call and bring business before special meetings;

    ●
    requiring
    advance notice of stockholder proposals for business to be conducted at meetings of our stockholders and for nominations of candidates
    for election to our board of directors;

    ●